Evidence map›Paper›PMID 40369419›Full record

ArticleBMC cardiovascular disorders2025

Different impact of female gender on the outcome of catheter ablation between paroxysmal and persistent atrial fibrillation.

Wei Du, Wenwu Zhu, Hao Yang, Qingshan Dong, YaLan Fei, Xianjin Li, Shijie Li, Bing Han

Abstract readComparative Study
In one paragraph

Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Women's cardiovascular health in 2025:Saudi medical journal · 2026
    Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wei Du *Division of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Institute of Cardiovascular Disease, Xuzhou, Jiangsu, 221009, China.
Wenwu Zhu *Division of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Institute of Cardiovascular Disease, Xuzhou, Jiangsu, 221009, China.
Hao YangDivision of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Institute of Cardiovascular Disease, Xuzhou, Jiangsu, 221009, China.
Qingshan DongDivision of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Institute of Cardiovascular Disease, Xuzhou, Jiangsu, 221009, China.
YaLan FeiDivision of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Institute of Cardiovascular Disease, Xuzhou, Jiangsu, 221009, China.
Xianjin LiDivision of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Institute of Cardiovascular Disease, Xuzhou, Jiangsu, 221009, China.
Shijie LiDivision of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Institute of Cardiovascular Disease, Xuzhou, Jiangsu, 221009, China.
Bing HanDivision of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Institute of Cardiovascular Disease, Xuzhou, Jiangsu, 221009, China. hbing7777@163.com.ORCID 0000-0002-3523-0573

Funding

the National Natural Science Foundation of China 82370329the Outstanding Talent Fund Project XYFY202336the Youth medical innovation project of the Xuzhou Health Commission XWKYHT20230082
6 · The paper itself

Abstract

backgroundThe impacts of gender on the outcome of atrial fibrillation (AF) ablation have been studied previously with contradictory results. Given the heterogeneities in clinical and pathophysiological characteristics between paroxysmal and persistent AF, gender impacts on post-ablation recurrence might differ depending on the type of AF.

aimsThis study aimed to investigate the differing impacts of female gender on catheter ablation outcomes between paroxysmal and persistent AF. METHODS AND

resultsA total of 857 patients (537 (62.7%) males and 320 (37.3%) females) undergoing de novo catheter ablation of AF were included in this retrospective study. Gender differences in ablation outcomes for different types of AF were compared. Of all patients, 476 were diagnosed with paroxysmal AF (PAF) and 381 with persistent AF (PeAF). Compared to male patients, female patients were older (64.0 ± 8.9 vs. 59.5 ± 10.7 years, P < 0.001), and more likely to have PAF (64.4% vs. 50.3%, P < 0.001). During a median follow-up of 53 [37-72] months, the total atrial tachyarrhythmia (ATa) recurrence rate after a single procedure was 35.4%, with no difference between male and female patients (34.5% vs. 36.9%, P = 0.473). For PAF, the recurrence was slightly higher in males than in females (37.4% vs. 30.1%, P = 0.096). On the contrary, for PeAF, females had a significantly higher risk of recurrence than males (49.1% vs. 31.5%, P = 0.001). The multivariate Cox regression analysis showed that female gender was an independent predictor of post-ablation recurrence only in PeAF (HR = 1.686; 95% CI 1.196-2.377, P = 0.003).

conclusionsThe female gender had different impacts on the outcome of catheter ablation between PAF and PeAF. The ATa recurrence was significantly higher in females than males only for PeAF. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Atrial FibrillationCatheter AblationHealth Status DisparitiesAgedFemaleHeart RateHumansMaleMiddle AgedRecurrenceRetrospective StudiesRisk AssessmentRisk FactorsSex FactorsTime FactorsTreatment OutcomeAtrial fibrillationGender, femaleRadiofrequency catheter ablationRecurrence

Identifiers

PMID40369419
PMCPMC12079952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.